Pathogenic rod-shaped bacteria are responsible for causing many human infectious diseases such as meningitis and cholera. A wide variety of these bacteria are becoming tolerant to current antibiotics, rendering treatments ineffective. It is therefore of critical importance to understand the mechanisms used by these bacteria to evade antibiotics.
Abul Tarafder and colleagues from Tanmay Bharat’s group in the Dunn School have identified a mechanism by which the rod-shaped bacterium, Pseudomonas aeruginosa, can evade antibiotics by surrounding its cells with a self-made protective casing. The bacteria produce a symbiotic filament-shaped phage, Pf4, that phase-separates into spindle-shaped liquid crystals. These encapsulate bacterial cells, preventing effective concentrations of antibiotic reaching the cell, thus ensuring bacterial survival. Interestingly, the authors found that this phage-mediated antibiotic tolerance mechanism is profoundly influenced by biophysical size and shape complementarity rather than the biochemical properties of the phage and bacteria, as the phage liquid crystals could encapsulate inanimate rods of comparable size to bacteria. This suggests that the mechanism of encapsulation by protective casings could be a general strategy adopted by many bacteria to evade antibiotics. This new knowledge is applicable to a wide variety of pathogenic bacteria so could have widespread implications on the development of novel methods to combat antibiotic tolerance.
Tarafader, AK, von Kügelgen A, Mellul AJ, Schulze U, Aarts DGAL, Bharat TAM (2020). Phage liquid crystalline droplets form occlusive sheaths that encapsulate and protect infectious rod-shaped bacteria.
PNAS pii: 201917726. doi: 10.1073/pnas.1917726117.
PARP1 is a poly [ADP-ribose] polymerase that can sense DNA damage and facilitate the choice of repair pathway. Currently, PARP1 inhibitors are the preferred treatment for carcinomas which are already deficient in DNA damage repair through acquired BRCA1/2 mutations.
In their previous work, Ivan Ahel group showed that the PARP1 inhibitor efficacy is greatly increased in cells lacking HPF1, a PARP1 interacting protein. In cells, PARP1 preferentially adds poly ADP-ribose to serine residues of proteins, while in vitro PARP1 modifies aspartate and glutamate residues. Strikingly, adding HPF1 to an in vitro reaction corrected PARP1 specificity to serine. Therefore, the group concluded that HPF1 likely plays a crucial part in PARP1 function.
In a recent publication from Ivan Ahel lab, Marcin Suskiewicz, Florian Zobel, and colleagues show that HPF1 directly contributes to the PARP1 active site with substrate binding and catalytic residues. The strong HPF1-PARP1 interaction is opposed by an autoinhibitory region of PARP1. This region is known to locally unfold on binding DNA lesions. Therefore, the authors propose that the complex formation is a regulatory mechanism restricting PARP1 activity until suitable cues, such as DNA damage induced PARP1 DNA binding, present themselves. This work hugely contributed to our mechanistic understanding of ADP-ribosylation synthesis and reversal. Most importantly, the authors provided the clinical community with an important puzzle piece that could help explain and predict reactions to PARP1 inhibitors.
Suskiewicz MJ, Zobel F, Ogden TEH, Fontana P, Ariza A, Yang JC, Zhu K, Bracken L, Hawthorne WJ, Ahel D, Neuhaus D, Ahel I (2020). HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
Nature (2020). https://doi.org/10.1038/s41586-020-2013-6
The human body defends itself from infection by utilising a complex and diverse array of weapons held by the immune system. One important element of the innate immune response is the complement system (also known as the complement cascade), which enhances the ability of immune soldiers such as antibodies to attack and destroy invading pathogens. Overactivation of the complement system can lead to adverse effects such as hyper-inflammation, autoimmunity, etc. A number of disease-causing organisms, including biting ticks, have evolved ways to suppress the complement system and can therefore overcome this attack. The prospect of identifying inhibitors of this system has long been sought, with the promise of therapeutic potential.
Martin Reichhardt and colleagues from Susan Lea’s lab have now uncovered a novel class of complement inhibitors, named the CirpT family, from tick saliva. They showed binding of CirpT1 to complement C5, one of the pointy ends of the complement pathway spear, via a site not targeted by already known inhibitors. Using cryo-electron microscopy and X-ray crystallography, they uncovered that CirpT1 obstructs the interaction and cleavage of complement C5 by C5-convertase, a critical final step in the complement pathway activation. The mechanistic insight into this unique mode of action by CirpT1 certainly provides a platform to further investigate the effect of other complement system inhibitors and also to design potential therapeutic agents.
Reichhardt MP, Johnson S, Tang T, Morgan T, Tebeka N, Popitsch N, Deme JC, Jore MM, Lea SM (2020). An inhibitor of complement C5 provides structural insights into activation
PNAS 117 (1): 362-370
R-Loops are nucleic acid structures that have been implicated in both DNA damage and DNA repair processes. They tend to form during transcription, when a growing RNA strand invades the DNA to form an RNA:DNA hybrid. R-Loops contain single-stranded DNA, a type of DNA which has been shown to possess the potential to initiate transcription.
By forming these structures in vitro, researchers from the Proudfoot Lab demonstrated that R-Loops are indeed able to promote transcription. The team then moved into cells to find out what sort of transcripts these R-Loops might be initiating. When they removed the R-Loops using a specific enzyme called RNase H1, they found that levels of antisense long non-coding RNAs (lncRNA) were reduced when compared with cells which had not been expressing the RNase. Furthermore, the researchers showed that these RNase-sensitive lncRNA transcripts were often formed adjacent to R-Loops, suggesting that their formation is R-Loop dependent.
lncRNA may form from protein-coding genes but do not code for proteins themselves. Their function is enigmatic, and little was previously known about how lncRNA are produced. This study offers insight into their origin, as well as positing a novel function for R-Loops in our genome.
Tan-Wong SM, Dhir S, Proudfoot NJ (2019). R-Loops Promote Antisense Transcription across the Mammalian Genome.
Mol. Cell 76(4):600-616.e6
RNA, a nucleic acid important for protein production and regulation, consists of only 4 bases. However, a large amount of variation can be achieved by adding modifications. One such modification is N6-methyladenosine (m6A), where the adenosine in RNA has a methyl group (-CH3) added. Therefore, the genomic language can be more complicated than at first sight.
Natalia Gromak’s group from the Dunn School, in collaboration with Alexey Ruzov’s group at the University of Nottingham and others, has identified a role of m6A in the regulation of genome stability in human pluripotent stem cells. They found it performs this role through control of the number of R-loops. These structures consist of a RNA:DNA hybrid and unpaired single-stranded DNA and are involved in regulating gene expression and telomere length. It is important to regulate R-loop numbers as an excess of these structures can lead to cell growth retardation and an increase in DNA double-strand breaks, associated with neurodegeneration and cancer.
The researchers found that the number of R-loops containing m6A on the RNA portion varied throughout the cell cycle, rising in levels during the lead up to mitosis. By investigating a knock-out cell line, they identified that an increase in m6A in R-loops leads to mRNA degradation through the m6A reader YTHDF2. Therefore, m6A in R-loops acts as a signal to promote R-loop removal. This is important for maintaining genome stability and healthy cells.
Abakir A, Giles TC, Cristini A, Foster JM, Dai N, Starczak M, Rubio-Roldan A, Li M, Eleftheriou M, Crutchley J, Flatt L, Young L, Gaffney DJ, Denning C, Dalhus B, Emes RD, Gackowski D, Corrêa Jr IR, Garcia-Perez JL, Klungland A, Gromak N, Ruzov A. (2020). N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells
Nature Genetics https://doi.org/10.1038/s41588-019-0549-x
Gram-negative bacteria are widespread, and can be harmful, causing antibiotic resistant infections, which are difficult to treat. Most bacteria have a protective surface layer made of proteins, termed S-layer. Although S-layer proteins are the most abundant class of proteins on earth, atomic resolution details of S-layers are not available. Therefore, the mechanisms of the assembly of S-layers in prokaryotes are poorly understood.
Andriko von Kügelgen from Tanmay Bharat’s lab together with colleagues, have successfully obtained a structure of the S-layer from the Gram-negative bacterium, Caulobacter crescentus, bound to the cell membrane via long sugars called lipopolysaccharides. By using a combination of electron cryo-microscopy, electron tomography, native mass spectrometry and molecular dynamics techniques, they have deduced the in-situ structure of lipopolysaccharide and the bound S-layer as it is found on cells. This study highlights the promising future of structural biology with atomic structure determination possible directly inside cells, with profound implications on structure-based drug design.
von Kügelgen A, Tang H, Hardy GG, Kureisaite-Ciziene D, Brun YV, Stansfeld PJ, Robinson CV, Bharat TAM. (2019). In Situ Structure of an Intact Lipopolysaccharide-Bound Bacterial Surface Layer
Dendritic cells (DCs) are key players in our immune response. A subset, called CD141+ DCs, are particularly effective in presenting tumour fragments that prime other immune cells against cancer. This makes them attractive immunotherapy candidates. Unfortunately, this subset is incredibly rare, making it impossible to harvest from patients in significant numbers. Induced pluripotent stem cells (iPSCs) offer a possible solution; they have the potential to differentiate into any somatic cell type, allowing production of a large CD141+ DC supply. However, DCs produced this way resemble foetal cells with underdeveloped immunogenicity.
Paul Fairchild’s lab tackled this arrested development by taking advantage of iPSCs’ ‘epigenetic memory’ – DNA modifications which can be retained over generations. In a departure from the standard protocol of generating iPSCs from fibroblasts, they forced common DCs into a stem cell-like state by driving transient expression of stem cell factors. The iPSCs produced were then induced to form rare DCs effective against cancers. The idea was that these iPSCs would retain expression of certain DC genes, aiding development of the rare DCs. Indeed, they demonstrated that the derived DCs resembled adult cells, with strong immunogenicity. By harnessing these cells and forcing them to present tumour fragments of choice, cancer patients could be vaccinated against their disease to enhance their immune response.
Horton C, Davies T J, Lahiri P, Sachamitr P, Fairchild PJ (2019). iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in i
The nucleus is the brain centre of the cell and it is compartmentalised by a physical barrier called the nuclear envelope. The latter consists of an outer nuclear membrane, contiguous with the endoplasmic reticulum and an inner nuclear membrane, which protrudes at several points inside the nucleus to form structures called nucleoplasmic reticulum. Studies have shown that altered nucleoplasmic reticulum is often associated with disease states but also occurs in cells under physiological conditions.
In human endometrial cells, during a specific time frame of the menstrual cycle, structures highly similar to nucleoplasmic reticulum called the nucleolar channel system, are observed. These structures are sensitive to hormones such as progesterone and oestrogen and their absence in endometrial cells has been linked to infertility.
Pytowski and colleagues from the Vaux lab have now established an endometrial cellular model to study the hormones-induced formation of nucleoplasmic reticulum. They found that, similar to what was previously observed under pathological conditions, normal physiological manifestation of these structures also require newly synthesised membrane phospholipids and nascent lamina proteins, albeit independent of the cell cycle. The mechanism how hormones regulate nucleoplasmic reticulum formation in endometrial cells is still unclear, but this new cellular model will be a useful tool in further understanding this phenomenon, and potentially the link to fertility.
Pytowski L, Drozdz MM, Jiang H, Hernandez Z, Kumar K, Knott E, Vaux DJ. (2019) Nucleoplasmic Reticulum Formation in Human Endometrial Cells is Steroid Hormone Responsive and Recruits Nascent Components.
Int J Mol Sci. 20(23).pii: E5839.
While some proteins in the cell function on their own, most have to assemble into multiprotein complexes to perform their function. Subunits failing to integrate into a complex, may become toxic and must be degraded. It is not clear how the cell identifies these “orphan” subunits and distinguishes them from newly made subunits which are yet to be utilized. While investigating this process in the context of protein complexes destined for endoplasmic reticulum (ER) membrane, Dr. Nivedita Natarajan and her colleagues from Prof. Carvalho group made an unexpected observation: many unassembled subunits were degraded only in the inner nuclear membrane, a highly specialized region of the ER.
The ER membrane is continuous with the inner nuclear membrane (INM), however, the functions and protein content of ER and INM are quite different. In their previous work, the Carvalho laboratory showed that ER proteins which erroneously diffused into the INM are recognised and degraded by the Asi protein complex. Dr. Natarajan and colleagues found that the same complex is responsible for degradation of orphan/unassembled subunits of ER localized complexes. The authors concluded that restriction of quality control of unassembled subunits to the INM provides a mechanism protecting the complex subunits from premature degradation. Their work was developed using baker’s yeast as a model system. In the future, it will be interesting to investigate whether spatial restricted quality control processes operate in higher eukaryotes, like humans.
Natarajan N, Foresti O, Wendrich K, Stein A, Carvalho P (2019). Quality Control of Protein Complex Assembly by a Transmembrane Recognition Factor.
Mol Cell. pii: S1097-2765(19)30763-4
Cell division is a multi-stage process, which involves dividing the DNA into two daughter cells. Centrosomes organise microtubules, which help distribute chromosomes during cell division, as well as provide the cell with a structure. Centrosomes are made of two cylinders (called centrioles) wrapped in a pericentriolar material (PCM) which grows as the cell gets ready for division. The components that make up this PCM are conserved between most animals, thus working with Drosophila (fruit flies) can provide insights relevant to a variety of organisms.
Alvarez-Rodrigo et al, from the Raff lab, have studied the recruitment and subsequent organisation of some of the key components of the PCM in flies (Spd-2, Polo and Cnn). By making flies carrying mutant forms of Spd-2 that cannot interact with Polo they have discovered that these 3 key proteins have to co-operate in order for the PCM to grow in size in fly embryos. Identification of these interactions gives us a better understanding of the requirements for a properly functioning centrosome, thus developing our overall knowledge of the process of cell division, a process that is constantly happening within our bodies.
Alvarez-Rodrigo I, Steinacker TL, Saurya S, Conduit PT, Baumbach J, Novak ZA, Aydogan MG, Wainman A, Raff JW. Evidence that a positive feedback loop drives centrosome maturation in fly embryos.